Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 5/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.37 |
| ▸ | TRPC5 | Q9UL62 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.36 |
| ▸ | PARK7 | Q99497 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24305866 | 0.91 | CNR2 (0.48) | CNR2MEN1KMT2AMAPTABCB1 | |
| SCHEMBL23460345 | 0.90 | CNR2 (0.47) | CNR2ALDH1A1MAPTPARK7 | |
| SCHEMBL25323579 | 0.89 | CNR2 (0.46) | CNR2MEN1KMT2AKCNH2TMEM97 | |
| SCHEMBL25322463 | 0.86 | CNR2 (0.47) | CNR2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL26579484 | 0.85 | CNR2 (0.49) | CNR2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL24306468 | 0.84 | CNR2 (0.48) | CNR2ALDH1A1TRPC5PARK7KDM4E | |
| SCHEMBL25904794 | 0.81 | CNR2 (0.46) | CNR2MEN1KMT2AALDH1A1ABCB1 | |
| SCHEMBL26579485 | 0.78 | ABCB1 (0.53) | KMT2AABCB1HTR2AGRM2KCNH2 | |
| SCHEMBL26579398 | 0.78 | CNR2 (0.40) | CNR2 | |
| SCHEMBL25327069 | 0.77 | CNR2 (0.48) | CNR2MEN1KMT2AALDH1A1ABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230331672-A1 | 6-METHOXY-2-PHENETHYL ISOINDOLINE-1-ONE DERIVATIVE AND COMPOSITION FOR TREATING NEUROLOGICAL DISORDERS, COMPRISING SAME | CNG BIO CO., LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
| US-20230331672-A1 | 6-METHOXY-2-PHENETHYL ISOINDOLINE-1-ONE DERIVATIVE AND COMPOSITION FOR TREATING NEUROLOGICAL DISORDERS, COMPRISING SAME | CNG BIO CO., LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
| EP-4219450-A1 | 6-METHOXY-2-PHENETHYL ISOINDOLINE-1-ONE DERIVATIVE AND COMPOSITION FOR TREATING NEUROLOGICAL DISORDERS, COMPRISING SAME | CNG Bio Co., Ltd. (KR) | 2023-08-02 | — | — | EP | disclosed |
| EP-4219450-A1 | 6-METHOXY-2-PHENETHYL ISOINDOLINE-1-ONE DERIVATIVE AND COMPOSITION FOR TREATING NEUROLOGICAL DISORDERS, COMPRISING SAME | CNG Bio Co., Ltd. (KR) | 2023-08-02 | — | — | EP | disclosed |
| WO-2022065825-A1 | 6-METHOXY-2-PHENETHYL ISOINDOLINE-1-ONE DERIVATIVE AND COMPOSITION FOR TREATING NEUROLOGICAL DISORDERS, COMPRISING SAME | 씨엔지바이오 주식회사 | 2022-03-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230331672-A1 | 6-METHOXY-2-PHENETHYL ISOINDOLINE-1-ONE DERIVATIVE AND COMPOSITION FOR TREATING NEUROLOGICAL DISORDERS, COMPRISING SAME | NGF, BDNF, NTRK2 | CNR2 412/4885MEN1 1336/4885KMT2A 1937/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.